These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 11311748)

  • 1. 10-Phenylbutyryl-substituted anthracenones as inhibitors of keratinocyte growth and LTB(4) biosynthesis.
    Müller K; Breu K; Reindl H
    Eur J Med Chem; 2001 Feb; 36(2):179-84. PubMed ID: 11311748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antipsoriatic anthrones with modulated redox properties. 5. Potent inhibition of human keratinocyte growth, induction of keratinocyte differentiation, and reduced membrane damage by novel 10-arylacetyl-1,8-dihydroxy-9(10H)-anthracenones.
    Müller K; Reindl H; Breu K
    J Med Chem; 2001 Mar; 44(5):814-21. PubMed ID: 11262091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 10-omega-phenylalkyl-9(10H)-anthracenones as inhibitors of keratinocyte growth with reduced membrane damaging properties.
    Müller K; Breu K
    Bioorg Med Chem Lett; 1998 Nov; 8(22):3211-6. PubMed ID: 9873705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antipsoriatic anthrones with modulated redox properties. 3. 10-thio-substituted 1,8-dihydroxy-9(10H)-anthracenones as inhibitors of keratinocyte growth, 5-lipoxygenase, and the formation of 12(S)-HETE in mouse epidermis.
    Müller K; Huang HS; Wiegrebe W
    J Med Chem; 1996 Aug; 39(16):3132-8. PubMed ID: 8759634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 10-alpha-Aminoacyl-9(10H)-anthracenones: inhibition of 12(S)-HETE biosynthesis and HaCaT cell growth.
    Müller K; Breu K
    Arch Pharm (Weinheim); 1999 Jan; 332(1):31-5. PubMed ID: 10073141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simple analogues of anthralin: unusual specificity of structure and antiproliferative activity.
    Müller K; Prinz H; Gawlik I; Ziereis K; Huang HS
    J Med Chem; 1997 Nov; 40(23):3773-80. PubMed ID: 9371243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antipsoriatic anthrones with modulated redox properties. 2. Novel derivatives of chrysarobin and isochrysarobin--antiproliferative activity and 5-lipoxygenase inhibition.
    Müller K; Leukel P; Ziereis K; Gawlik I
    J Med Chem; 1994 May; 37(11):1660-9. PubMed ID: 8201600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterocyclic substituted anthralin derivatives as inhibitors of keratinocyte growth and inducers of differentiation.
    Müller K; Reindl H; Breu K
    Bioorg Med Chem Lett; 2001 Jan; 11(1):47-50. PubMed ID: 11140730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cornified envelope formation by anthralin, simple analogues, and related anthracenones.
    Müller K; Reindl H
    Arch Pharm (Weinheim); 2001 Mar; 334(3):86-92. PubMed ID: 11315339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological evaluation of novel 10-benzyl-substituted 4,5-dichloro-10H-anthracen-9-ones as inhibitors of keratinocyte hyperproliferation.
    Kratz U; Prinz H; Müller K
    Eur J Med Chem; 2010 Nov; 45(11):5278-85. PubMed ID: 20828887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depsides as non-redox inhibitors of leukotriene B(4) biosynthesis and HaCaT cell growth, 2. Novel analogues of obtusatic acid.
    Kumar KC S; Müller K
    Eur J Med Chem; 2000 Apr; 35(4):405-11. PubMed ID: 10858601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential antipsoriatic agents: lapacho compounds as potent inhibitors of HaCaT cell growth.
    Müller K; Sellmer A; Wiegrebe W
    J Nat Prod; 1999 Aug; 62(8):1134-6. PubMed ID: 10479319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antipsoriatic anthrones with modulated redox properties. 1. Novel 10-substituted 1,8-dihydroxy-9(10H)-anthracenones as inhibitors of 5-lipoxygenase.
    Müller K; Gürster D; Piwek S; Wiegrebe W
    J Med Chem; 1993 Dec; 36(25):4099-107. PubMed ID: 8258834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity relationship studies of acridones as potential antipsoriatic agents. 2. Synthesis and antiproliferative activity of 10-substituted hydroxy-10H-acridin-9-ones against human keratinocyte growth.
    Putic A; Stecher L; Prinz H; Müller K
    Eur J Med Chem; 2010 Nov; 45(11):5345-52. PubMed ID: 20850910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-activity relationship studies of acridones as potential antipsoriatic agents. 1. Synthesis and antiproliferative activity of simple N-unsubstituted 10H-acridin-9-ones against human keratinocyte growth.
    Putic A; Stecher L; Prinz H; Müller K
    Eur J Med Chem; 2010 Aug; 45(8):3299-310. PubMed ID: 20452101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-activity relationships for the formation of secondary radicals and inhibition of keratinocyte proliferation by 9-anthrones.
    Hayden PJ; Free KE; Chignell CF
    Mol Pharmacol; 1994 Jul; 46(1):186-98. PubMed ID: 8058052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multifunctional inhibition by anthralin in nonstimulated and chemotactic factor stimulated human neutrophils.
    Schröder JM; Kosfeld U; Christophers E
    J Invest Dermatol; 1985 Jul; 85(1):30-4. PubMed ID: 2989375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current status and recent developments in anthracenone antipsoriatics.
    Müller K
    Curr Pharm Des; 2000 Jun; 6(9):901-18. PubMed ID: 10828315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-function relationship of new anthralin derivatives assayed for growth inhibition and cytotoxicity in human keratinocyte cultures.
    Bonnekoh B; Tanzer H; Seidel M; Geisel J; Merk HF; Mahrle G; Wiegrebe W
    Arch Pharm (Weinheim); 1991 Nov; 324(11):899-906. PubMed ID: 1804068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antipsoriatic anthrones with modulated redox properties. 4. Synthesis and biological activity of novel 9,10-dihydro-1,8-dihydroxy-9-oxo-2-anthracenecarboxylic and -hydroxamic acids.
    Müller K; Prinz H
    J Med Chem; 1997 Aug; 40(17):2780-7. PubMed ID: 9276024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.